to describe the protein parameters. The LEaP module in the AMBER software package (version 11) was used to add the missing hydrogen atoms of the proteins. Each complex was neutralized by adding 4 sodium counterions and solvated in a rectangular pre-equilibrated box of TIP3P water with at least a 10 Å distance around the complex.
All MD simulations were performed using AMBER11. Firstly, minimizations were carried out for both solvated complexes. Each minimization was performed using the steepest decent method, switched to the conjugate gradient method every 3000 steps. The first minimization using a harmonic restraints weight of 500.0 kcal/(mol· Å 2 ) was applied to all of the protein atoms. Following this step, all atoms were released. Then, each system was warmed up from 0 to 300 K with 50 ps in the NVT ensemble. Next, each system was equilibrated for 300 ps to adjust the solvent density under 1 atm of pressure in the NPT ensemble. In the heating and equilibrium, all atoms of the protein were restrained by a harmonic restraint weight of 10.0 kcal/(mol.Å 2 ). Finally, the MD simulation was run by releasing all of the restrains on each system for a total of 100 ns in the NPT ensemble, keeping the temperature at 300.0 K and the pressure at 1 atm. During the simulations, a time step of 2 fs was used for the equations of motion, and periodic boundary conditions were employed to avoid edge effects in the calculation. The electrostatic interactions were calculated by the particle-mesh Ewald (PME) method 5 with a cutoff of 10.0 Å. The SHAKE algorithm was used to constrain the bond lengths involving hydrogens. 6,7 The motion and equilibration of the MD trajectories were monitored using the root-mean-square displacement (RMSD) values of the backbone atoms by respecting the starting structure. Both of the complexes were stable during the last 20 ns. Principle component analysis (PCA) was performed using the stable trajectory (last equalized 20 ns trajectory) of the simulation to identify the change in the conformation space of PDE10A p.Pro360Ala. Table S1 . All 574 allosteric protein-coding genes.
See the attached excel file Table_S1.xlsx. a : Significantly mutated allosteric proteins predicted with q < 0.1 b : Mutated allosteric proteins predicted with P < 0.05 as well as at least two variants at allosteric sites. *: Gene with underline means that it has been reported to involve in individual cancer type in the literature labeled at the top right-hand corner.
